Complete response to induction therapy in patients with Myc-positive and double-hit non-Hodgkin lymphoma is associated with prolonged progression-free survival

Author： Cohen Jonathon B.   Geyer Susan M.   Lozanski Gerard   Zhao Weiqiang   Heerema Nyla A.   Hall Nathan C.   Nagar Veena A.   Hemminger Jessica A.   Jones Jeffrey A.   Porcu Pierluigi   Christian Beth A.   Baiocchi Robert A.   Maddocks Kami J.   Flynn Joseph M.   Devine Steven M.   Blum Kristie A.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|11|1677-1685

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.11, 2014-06, pp. : 1677-1685

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Relationship between response rates and median progression‐free survival in non‐Hodgkin's lymphoma: A meta‐analysis of published clinical trials

By  

Hematological Oncology (Electronic), Vol. 36, Iss. 1, 2018-02 ,pp. : 37-43

John Wiley & Sons Inc

Access to resources Recommend Favorite

MYC-associated and double-hit lymphomas: A review of pathobiology, prognosis, and therapeutic approaches

By  

Cancer, Vol. 120, Iss. 24, 2014-12 ,pp. : 3884-3895

Blackwell Publishing

Access to resources Recommend Favorite

Pharmacogenetic considerations for non-Hodgkin's lymphoma therapy

By Espirito Santo Ana   Medeiros Rui  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 12, 2013-12 ,pp. : 1625-1634

Informa Healthcare

Access to resources Recommend Favorite

Plerixafor: In Patients with Non-Hodgkin's Lymphoma or Multiple Myeloma

By Wagstaff Antona J.  

Drugs, Vol. 69, Iss. 3, 2009-02 ,pp. : 319-326

Adis International

Access to resources Recommend Favorite

Immunosuppressants: non-Hodgkin's lymphoma in patients with IBD

By  

Inpharma, Vol. 1, Iss. 1323, 2002-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite